Genetics of Parkinson's disease.

Publisher Summary This chapter presents an overview of the genetics of Parkinson's disease (PD). Parkinsonism is clinically characterized by the triad of tremor, rigidity, and bradykinesia. PD is the most common cause of Parkinsonism and the second most prevalent neurodegenerative disorder after Alzheimer's disease. Earlier, PD was thought to have no genetic basis, and epidemiological data appeared to support this view. Cross-sectional studies also suggested that either there is no genetic basis, or that it is only evident in early-onset PD. Differing disease concordance rates between monozygotic and dizygotic twins in longitudinal studies including those using 18F-dopa positron emission tomography support heritability in PD. Studies show that Parkin mutations usually occur either as homozygous or compound heterozygous mutations (with different mutations in both alleles). However, many have been reported in which, despite extensive screening, only one of the alleles appears to be mutated. This chapter starts with a discussion on genetics of familial Parkinson's disease and then explains the term Parkinsonism-plus genes. The chapter concludes with explaining sporadic PD, genetic associations, and familial genes.

[1]  R. Crowther,et al.  Tau Mutations Cause Frontotemporal Dementias , 1998, Neuron.

[2]  K. Kosik,et al.  Suppression of Radixin and Moesin Alters Growth Cone Morphology, Motility, and Process Formation In Primary Cultured Neurons , 1998, The Journal of cell biology.

[3]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[4]  C. Marsden,et al.  Dopa‐responsive dystonia: A clinical and molecular genetic study , 1998, Annals of neurology.

[5]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[7]  H Okazaki,et al.  Hereditary form of parkinsonism—dementia , 1998, Annals of neurology.

[8]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[9]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[10]  C. Marsden,et al.  Sequencing of the α-Synuclein Gene in a Large Series of Cases of Familial Parkinson's Disease Fails to Reveal any Further Mutations , 1998 .

[11]  M. Farrer,et al.  Low frequency of α‐synuclein mutations in familial Parkinson's disease , 1998, Annals of neurology.

[12]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[13]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[14]  M. Pericak-Vance,et al.  Genetic Complexity and Parkinson's Disease , 1997 .

[15]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[16]  M. Xiong,et al.  Fine-scale genetic mapping based on linkage disequilibrium: theory and applications. , 1997, American journal of human genetics.

[17]  A A Schäffer,et al.  Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. , 1997, American journal of human genetics.

[18]  M. Polymeropoulos,et al.  Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.

[19]  C. Marsden,et al.  The GTP-cyclohydrolase I gene in atypical Parkinsonian patients: a clinico-genetic study , 1996, Journal of the Neurological Sciences.

[20]  A. Ishikawa,et al.  Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism , 1996, Neurology.

[21]  Y. Agid,et al.  Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation. , 1995, American journal of human genetics.

[22]  N. Risch,et al.  Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population , 1995, Nature Genetics.

[23]  A D Roses,et al.  APOE is a major susceptibility gene for Alzheimer's disease. , 1994, Current opinion in biotechnology.

[24]  A. Mubaidin,et al.  Pallido‐pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor‐Rakeb syndrome , 1994, Acta neurologica Scandinavica.

[25]  S. Tsuji,et al.  Familial juvenile parkinsonism , 1994, Neurology.

[26]  X. Breakefield,et al.  Rapid‐onset dystonia‐parkinsonism , 1993, Neurology.

[27]  R. G. Lee,et al.  Parkinson's disease , 1993, Neurology.

[28]  KM McGrail,et al.  Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[30]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[31]  R. Mayer,et al.  Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[32]  J. Goldman,et al.  Lewy bodies of Parkinson's disease contain neurofilament antigens. , 1983, Science.

[33]  A. Delacourte,et al.  Normal and pathological Tau proteins as factors for microtubule assembly. , 1997, International review of cytology.

[34]  D W Dickson,et al.  Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration. , 1996, Journal of neural transmission. Supplementum.